Publication Date
4-1-2021
Journal
Transplant International
DOI
10.1111/tri.13840
PMID
33545741
PMCID
PMC8013003
PubMedCentral® Posted Date
2-26-2021
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
COVID-19, COVID-19 Vaccines, Europe, Health Care Rationing, Health Policy, Health Services Accessibility, Humans, Kidney Failure, Chronic, Kidney Transplantation, Pandemics, Perioperative Care, Tissue and Organ Procurement, United States, Waiting Lists, COVID‐19, kidney transplantation, mortality, wait list
Abstract
The COVID‐19 pandemic has significantly changed the landscape of kidney transplantation in the United States and worldwide. In addition to adversely impacting allograft and patient survival in postkidney transplant recipients, the current pandemic has affected all aspects of transplant care, including transplant referrals and listing, organ donation rates, organ procurement and shipping, and waitlist mortality. Critical decisions were made during this period by transplant centers and individual transplant physicians taking into consideration patient safety and resource utilization. As countries have begun administering the COVID vaccines, new and important considerations pertinent to our transplant population have arisen. This comprehensive review focuses on the impact of COVID‐19 on kidney transplantation rates, mortality, policy decisions, and the clinical management of transplanted patients infected with COVID‐19.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, COVID-19 Commons, Epidemiology Commons, Medical Sciences Commons, Nephrology Commons